When Cryo-Save, a private company in Switzerland, offered a guarantee of having suitable stem cell material should a child get sick in the future, parents thought they were making an investment. ‘I imagined that anything concerning the health of children was well regulated,’says Pierre, a father. But the company went bankrupt and the data and stem cells of some 250,000 families across Europe was scattered abroad in what journalist Sylvie Logean describes as an act ‘to avoid considerable image damage’.“I know that profit always comes first, for any corporation,’ reflects mother Kinda. What, then, is the future for our biological material and private medical data?